-
1
المؤلفون: Alireza Vatanara, Abdolhossein Rouholamini Najafabadi, Elham Gholami, Sima Rafati, Delaram Doroud, Rouhollah Vahabpour, Farnaz Zahedifard
المساهمون: Institut Pasteur d'Iran, Réseau International des Instituts Pasteur (RIIP), School of Pharmacy [TUMS, Teheran, Iran], Tehran University of Medical Sciences (TUMS), D. Doroud thanks Pasteur Institute of Iran and Tehran University of Medical sciences for supporting her PhD studentship., The authors thank Dr. M. Amanzadeh, Cell Bank of Pasteur Institute of Iran, for his advice and guidance on the MTT assay and Dr. A. Saadat and Dr. E. Moazeni, Pharmaceutics Dept., Faculty of Pharmacy, Tehran University of Medical Sciences, for their technical support on size and zeta potential determinations. We are also grateful for English revision by Amir Mizbani, D. Doroud thanks Pasteur Institute of Iran and Tehran University of Medical Sciences for Supporting her PhD studentship., The authors thank Dr. M. Amanzadeh, Cell Bank Dept., Pasteur Institute of Iran, for his advice and guidance on the MTT assay.
المصدر: Journal of Pharmacy and Pharmaceutical Sciences
Journal of Pharmacy and Pharmaceutical Sciences, Canadian Society for Pharmaceutical Sciences, 2010, 13 (3), pp.320-335. ⟨10.18433/J3R30T⟩
Journal of Controlled Release
Journal of Controlled Release, Elsevier, 2010, 148 (1), pp.e105-106. ⟨10.1016/j.jconrel.2010.07.079⟩
Scopus-Elsevier
Journal of Pharmacy & Pharmaceutical Sciences, Vol 13, Iss 3 (2010)مصطلحات موضوعية: Cystein proteinase, Drug Evaluation, Preclinical, lcsh:RS1-441, Pharmaceutical Science, Tetrazolium Salts, 02 engineering and technology, MESH: Dogs, chemistry.chemical_compound, 0302 clinical medicine, Drug Delivery Systems, Cysteine Proteases, Chlorocebus aethiops, Zeta potential, Vaccines, DNA, MESH: Animals, 030212 general & internal medicine, Cytotoxicity, Leishmaniasis, 0303 health sciences, MESH: Vaccines, DNA/administration & dosage, Cetyl palmitate, Formazans, MESH: Nanoparticles*/administration & dosage, Transfection, MESH: Tetrazolium Salts, 021001 nanoscience & nanotechnology, Lipids, 3. Good health, MESH: COS Cells, MESH: Cysteine Proteases/genetics, Biochemistry, MESH: Cysteine Proteases/metabolism, COS Cells, MESH: Drug Evaluation, Preclinical, Delivery system, 0210 nano-technology, Plasmids, Cell Survival, Green Fluorescent Proteins, Heterologous, MESH: Leishmaniasis/metabolism, Biology, DNA vaccination, lcsh:Pharmacy and materia medica, Excipients, 03 medical and health sciences, Dogs, MESH: Leishmaniasis/prevention & control, MESH: Plasmids, Cations, Solid lipid nanoparticle, medicine, Animals, MESH: Particle Size, Particle Size, MESH: Formazans, MESH: Cations, Gene, Leishmaniasis Vaccines, 030304 developmental biology, MESH: Excipients, Pharmacology, MESH: Transfection, lcsh:RM1-950, Cationic polymerization, MESH: Green Fluorescent Proteins/genetics, MESH: Nanoparticles*/analysis, medicine.disease, Virology, MESH: Lipids, MESH: Cercopithecus aethiops, In vitro, MESH: Leishmaniasis Vaccines/administration & dosage, lcsh:Therapeutics. Pharmacology, chemistry, Nanoparticles, [SDV.IMM.VAC]Life Sciences [q-bio]/Immunology/Vaccinology, MESH: Drug Delivery Systems, MESH: Cell Survival/drug effects, MESH: Nanoparticles
